RE: Telegram for Wigscoff8828 Feb 2021 19:48
Wigwammer- I think we all get it - of course it’s a balancing act as to the amount and the timing which I’m sure Duncan will judge sensibly as he’s a major share holder anyway, after all he will want to minimise the % dilution and yet achieve sufficient runway funds ( having regard of course to timing of the various inflection points which are likely to come through to promote this) In short, the whole reason for going on NASDAQ is to achieve bigger and better funding in a market that values biotech companies more highly.
We are all actually saying the same thing, the problem seems to be interpretation of the RNS wording. It’s worded so as to state the extreme case in order be fully transparent and comply with Nomad vetting .
We just have to trust Duncan’s judgement on how and when he promotes a fund raise but let’s remember it was actually his idea that got us into a SPAC vehicle listing on a much better market more used to investing in growth oriented biotechs. I’m sure the Americans will see our world leading position and the number of patents as highly valuable so we will re-rate before Duncan presses the button.
"The decision regarding how much to raise or whether to proceed or not, will depend on the prevailing market conditions, investor appetite and price, and there is no certainty that any such fundraising transaction will proceed nor what amount might be raised."
We each have different temperaments - glass half full and glass half empty judgments - let’s just trust in Duncan he got us this far, the NASDAQ future is bright and we are now well placed.
Sign In
Follow the stocks
